Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13025) 13025
Book Review (834) 834
Publication (460) 460
Book Chapter (61) 61
Book / eBook (60) 60
Conference Proceeding (20) 20
Newsletter (18) 18
Magazine Article (8) 8
Dissertation (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12531) 12531
animals (8288) 8288
humans (6845) 6845
rats (5327) 5327
male (5268) 5268
liver - enzymology (4749) 4749
liver neoplasms - enzymology (4139) 4139
female (3733) 3733
carcinoma, hepatocellular - enzymology (3258) 3258
mice (2673) 2673
oncology (2449) 2449
liver neoplasms, experimental - enzymology (2091) 2091
liver neoplasms - pathology (1772) 1772
middle aged (1753) 1753
liver (1534) 1534
cancer (1488) 1488
biochemistry & molecular biology (1423) 1423
carcinoma, hepatocellular - pathology (1418) 1418
adult (1358) 1358
aged (1346) 1346
liver - drug effects (1295) 1295
cell line, tumor (1187) 1187
expression (1104) 1104
tumor cells, cultured (1097) 1097
kinetics (1062) 1062
hepatocellular carcinoma (1020) 1020
liver neoplasms (968) 968
neoplasms, experimental - enzymology (947) 947
cell line (931) 931
liver - metabolism (906) 906
liver - pathology (898) 898
liver neoplasms - genetics (896) 896
time factors (861) 861
liver neoplasms, experimental - chemically induced (831) 831
liver cancer (773) 773
pharmacology & pharmacy (753) 753
apoptosis (750) 750
carcinoma, hepatocellular - genetics (735) 735
liver neoplasms - metabolism (730) 730
carcinoma, hepatocellular - metabolism (699) 699
enzymes (695) 695
rats, inbred strains (688) 688
cell biology (658) 658
toxicology (643) 643
cells (641) 641
immunohistochemistry (641) 641
liver neoplasms, experimental - pathology (637) 637
hepatoma (633) 633
dose-response relationship, drug (610) 610
microsomes, liver - enzymology (609) 609
neoplasms - enzymology (601) 601
tumors (589) 589
liver neoplasms - chemically induced (586) 586
abridged index medicus (581) 581
rats, inbred f344 (579) 579
metabolism (575) 575
neoplasm transplantation (574) 574
gastroenterology & hepatology (572) 572
gene expression (559) 559
research (552) 552
liver neoplasms - secondary (537) 537
transfection (531) 531
liver neoplasms - drug therapy (524) 524
enzyme induction (509) 509
carcinogenesis (507) 507
isoenzymes - metabolism (503) 503
molecular sequence data (501) 501
gene expression regulation, neoplastic (500) 500
proteins (490) 490
metastasis (489) 489
cells, cultured (485) 485
base sequence (484) 484
rat-liver (479) 479
prognosis (470) 470
rna, messenger - metabolism (469) 469
phosphorylation (463) 463
glutathione transferase - metabolism (460) 460
precancerous conditions - enzymology (441) 441
diethylnitrosamine (433) 433
hepatocellular-carcinoma (433) 433
rna, messenger - genetics (432) 432
carcinogens (429) 429
cytochrome p-450 enzyme system - metabolism (426) 426
enzyme induction - drug effects (424) 424
antineoplastic agents - pharmacology (420) 420
activation (415) 415
growth (415) 415
analysis (412) 412
mice, nude (410) 410
blotting, western (405) 405
liver diseases - enzymology (400) 400
induction (397) 397
carcinoma, hepatocellular - drug therapy (394) 394
cell proliferation (394) 394
apoptosis - drug effects (390) 390
liver neoplasms, experimental - metabolism (390) 390
kidney - enzymology (385) 385
alkaline phosphatase - blood (377) 377
rats, wistar (376) 376
liver cirrhosis - enzymology (368) 368
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (51) 51
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Scarborough Hospital - General (3) 3
St. Michael's Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (1) 1
Church Stacks (1) 1
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Pharmacy (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11771) 11771
Russian (369) 369
Japanese (232) 232
German (229) 229
Chinese (161) 161
French (145) 145
Italian (63) 63
Polish (51) 51
Spanish (43) 43
Ukrainian (13) 13
Hungarian (9) 9
Czech (8) 8
Romanian (8) 8
Croatian (5) 5
Danish (5) 5
Swedish (4) 4
Dutch (3) 3
Turkish (3) 3
Korean (2) 2
Slovak (2) 2
Bulgarian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Lysyl oxidase is essential for hypoxia-induced metastasis
by Chi, Jen-Tsan Ashley and Giaccia, Amato J and Nicolau, Monica and Dornhöfer, Nadja and Le, Quynh-Thu and Erler, Janine T and Jeffrey, Stefanie S and Kong, Christina and Bennewith, Kevin L
Nature, ISSN 0028-0836, 04/2006, Volume 440, Issue 7088, pp. 1222 - 1226
Metastasis is a multistep process responsible for most cancer deaths, and it can be influenced by both the immediate microenvironment (cell–cell or cell–matrix... 
BREAST-CANCER | MIGRATION | PATHWAYS | SPECIFICITY | RAS | MULTIDISCIPLINARY SCIENCES | CELL INVASION | GENE-EXPRESSION | MECHANISMS | MICE | TUMORS | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Neoplasm Transplantation | Humans | Lung Neoplasms - pathology | Cell Hypoxia | Lung Neoplasms - secondary | Neoplasm Metastasis - drug therapy | Female | Liver Neoplasms - pathology | Liver Neoplasms - secondary | Protein-Lysine 6-Oxidase - secretion | Liver Neoplasms - drug therapy | Neoplasms - enzymology | Survival Rate | Disease Progression | Neoplasms - drug therapy | Cell Movement - drug effects | Protein-Lysine 6-Oxidase - antagonists & inhibitors | Animals | Mice, Nude | Neoplasm Metastasis - pathology | Neoplasm Metastasis - physiopathology | Protein-Lysine 6-Oxidase - metabolism | Cell Line, Tumor | Mice | Neoplasms - pathology | Oncology | Hypoxia | Inhibitor drugs | Clinical outcomes | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Repression of the Long Noncoding RNA-LET by Histone Deacetylase 3 Contributes to Hypoxia-Mediated Metastasis
by Yang, Fu and Huo, Xi-song and Yuan, Sheng-xian and Zhang, Ling and Zhou, Wei-ping and Wang, Fang and Sun, Shu-han
Molecular Cell, ISSN 1097-2765, 03/2013, Volume 49, Issue 6, pp. 1083 - 1096
Recently, long noncoding RNAs (lncRNAs) were found to be dysregulated in a variety of tumors. However, it remains unknown how and through what molecular... 
CELLS | CHROMATIN | GENE | ANGIOGENESIS | HIF | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | EXPRESSION | CARCINOMA | CELL BIOLOGY | Neoplasm Transplantation | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Male | Carcinoma, Hepatocellular - secondary | Cell Hypoxia | Lung Neoplasms - secondary | Base Sequence | Carcinoma, Hepatocellular - genetics | Female | Liver Neoplasms - pathology | Acetylation | Liver Neoplasms - enzymology | Lung Neoplasms - genetics | Gene Expression | Lung Neoplasms - enzymology | Liver Neoplasms - genetics | Down-Regulation | RNA, Long Noncoding - genetics | Carcinoma, Hepatocellular - enzymology | Nuclear Factor 90 Proteins - metabolism | Animals | Mice, Nude | Cell Line, Tumor | Mice | Protein Processing, Post-Translational | Histone Deacetylases - physiology | Histones - metabolism | Nuclear Factor 90 Proteins - genetics | RNA, Long Noncoding - metabolism | Cell Movement | Medical colleges | Lung cancer | Colorectal cancer | Medical genetics | Development and progression | Antisense RNA | Metastasis | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Recognition of RNA N 6 -methyladenosine by IGF2BP proteins enhances mRNA stability and translation
by Huang, Huilin and Weng, Hengyou and Sun, Wenju and Qin, Xi and Shi, Hailing and Wu, Huizhe and Zhao, Boxuan Simen and Mesquita, Ana and Liu, Chang and Yuan, Celvie L and Hu, Yueh-Chiang and Hüttelmaier, Stefan and Skibbe, Jennifer R and Su, Rui and Deng, Xiaolan and Dong, Lei and Sun, Miao and Li, Chenying and Nachtergaele, Sigrid and Wang, Yungui and Hu, Chao and Ferchen, Kyle and Greis, Kenneth D and Jiang, Xi and Wei, Minjie and Qu, Lianghu and Guan, Jun-Lin and He, Chuan and Yang, Jianhua and Chen, Jianjun
Nature Cell Biology, ISSN 1465-7392, 03/2018, Volume 20, Issue 3, pp. 285 - 295
N-6-methyladenosine (m(6)A) is the most prevalent modification in eukaryotic messenger RNAs (mRNAs) and is interpreted by its readers, such as YTH... 
ZBP1 | CELLS | METHYLATION | STABILIZATION | BINDING PROTEINS | GENE-EXPRESSION | SITES | DIFFERENTIATION | DOMAINS | FAMILY | CELL BIOLOGY | Consensus Sequence | RNA-Binding Proteins - genetics | Protein Biosynthesis | Cell Proliferation | Humans | Gene Expression Regulation, Neoplastic | Uterine Cervical Neoplasms - pathology | RNA, Messenger - metabolism | Adenosine - genetics | HEK293 Cells | Female | Liver Neoplasms - pathology | Liver Neoplasms - enzymology | Binding Sites | Uterine Cervical Neoplasms - enzymology | Liver Neoplasms - genetics | RNA Processing, Post-Transcriptional | Neoplasm Invasiveness | RNA, Messenger - genetics | Fetal Blood - cytology | RNA Stability | Uterine Cervical Neoplasms - genetics | Hep G2 Cells | Adenosine - analogs & derivatives | Adenosine - metabolism | Protein Binding | HeLa Cells | Hematopoietic Stem Cells - enzymology | RNA-Binding Proteins - metabolism | Cell Movement | Post-transcription | Translation | Stability | Gene regulation | mRNA turnover | Homology | Shelf life | Myc protein | Gene expression | Insulin | Readers | Proteins | Conserved sequence | Ribonucleic acids | Recognition | Cancer | mRNA stability
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Arginase-1 Is Frequently Positive in Hepatoid Adenocarcinomas
by Chandan, Vishal S., MD and Shah, Sejal S., MD and Torbenson, Michael S., MD and Wu, Tsung-Teh, MD, PhD
Human Pathology, ISSN 0046-8177, 2016, Volume 55, pp. 11 - 16
Summary Hepatoid adenocarcinoma is a rare extrahepatic tumor, which shows morphological and immunohistochemical similarities to hepatocellular carcinoma (HCC).... 
Pathology | Hepatocellular carcinoma | Hepatoid adenocarcinoma | Hepar-1 | Glypican-3 | Arginase-1 | ɑ-Fetoprotein | α-Fetoprotein | alpha-Fetoprotein | HEPATOCELLULAR DIFFERENTIATION | IN-SITU-HYBRIDIZATION | PATHOLOGY | FEATURES | SENSITIVE MARKER | GASTRIC-CARCINOMA | GENE-EXPRESSION | OF-THE-LITERATURE | ALBUMIN MESSENGER-RNA | STOMACH | Immunohistochemistry | Predictive Value of Tests | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Humans | Middle Aged | Serum Albumin - genetics | Lung Neoplasms - pathology | Male | Stomach Neoplasms - pathology | Serum Albumin, Human | Adrenal Gland Neoplasms - enzymology | In Situ Hybridization | Carcinoma, Hepatocellular - genetics | Adult | Female | Liver Neoplasms - pathology | Adenocarcinoma - genetics | Liver Neoplasms - enzymology | Adrenal Gland Neoplasms - pathology | Lung Neoplasms - genetics | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Diagnosis, Differential | Reproducibility of Results | Lung Neoplasms - enzymology | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Pancreatic Neoplasms - pathology | Adenocarcinoma - enzymology | Pancreatic Neoplasms - enzymology | Pancreatic Neoplasms - genetics | Carcinoma, Hepatocellular - enzymology | Arginase - analysis | Biopsy | Carcinoma, Hepatocellular - pathology | Aged | Biomarkers, Tumor - genetics | Adrenal Gland Neoplasms - genetics | CEA (Oncology) | Studies | Stomach | Morphology | Metastasis | Endoscopy | Pancreas | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition
by Jung, H and Lee, K.P and Park, S.J and Park, J.H and Jang, Y.-S and Choi, S.-Y and Jung, J.-G and Jo, K and Park, D.Y and Yoon, J.H and Park, J.-H and Lim, D.-S and Hong, G.-R and Choi, C and Park, Y.-K and Lee, J.W and Hong, H.J and Kim, S and Park, Y.W
Oncogene, ISSN 0950-9232, 04/2008, Volume 27, Issue 18, pp. 2635 - 2647
TMPRSS4 is a novel type II transmembrane serine protease found at the cell surface that is highly expressed in pancreatic, colon and gastric cancer tissues.... 
Serine protease | Metastasis | E-cadherin | EMT | Invasion | TMPRSS4 | PROSTATE | MATRIPTASE | SURFACE PROTEOLYTIC-ENZYMES | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | serine protease | CELL BIOLOGY | BREAST-CANCER CELLS | MATRIX METALLOPROTEINASES | invasion | PLASMINOGEN-ACTIVATOR | ONCOLOGY | metastasis | GENETICS & HEREDITY | TRANSMEMBRANE SERINE PROTEASES | EXPRESSION | RNA, Small Interfering - genetics | Cadherins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Cell Movement - genetics | Neoplasm Metastasis | Serine Endopeptidases - genetics | Liver Neoplasms - pathology | Cadherins - genetics | Liver Neoplasms - enzymology | Liver Neoplasms - secondary | Neoplasm Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Lung Neoplasms - enzymology | Liver Neoplasms - genetics | Serine Endopeptidases - biosynthesis | Membrane Proteins - genetics | Epithelial Cells - pathology | Lung Neoplasms - therapy | Gastrointestinal Neoplasms - enzymology | Gastrointestinal Neoplasms - therapy | Cell Adhesion | Cell Movement - drug effects | Membrane Proteins - biosynthesis | Membrane Proteins - antagonists & inhibitors | Gene Expression Regulation, Enzymologic - genetics | Mice, Nude | Cell Communication - drug effects | Epithelial Cells - enzymology | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cadherins - antagonists & inhibitors | Mice | RNA-Binding Proteins - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Neoplasm Transplantation | RNA-Binding Proteins - genetics | Gastrointestinal Neoplasms - genetics | Lung Neoplasms - pathology | Liver Neoplasms - therapy | Gastrointestinal Neoplasms - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Cell Communication - genetics | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Animals | Biomarkers, Tumor - biosynthesis | Care and treatment | Control | Proteases | Cancer cells | Physiological aspects | Genetic aspects | Research | Risk factors | Oncology | Genetics | Cellular biology | Pancreatic cancer | Colorectal cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Arginase-1: A new immunohistochemical marker of hepatocytes and hepatocellular neoplasms
by Yan, Benjamin C and Gong, Can and Song, Jie and Krausz, Thomas and Tretiakova, Maria and Hyjek, Elizabeth and Al-Ahmadie, Hikmat and Alves, Venancio and Xiao, Shu-Yuan and Anders, Robert A and Hart, John A
American Journal of Surgical Pathology, ISSN 0147-5185, 08/2010, Volume 34, Issue 8, pp. 1147 - 1154
The distinction of hepatocellular carcinoma (HCC) from metastatic tumor in the liver often presents a diagnostic challenge that carries significant impact on... 
immunohistochemistry | liver | arginase | hepatocellular carcinoma | HepPar-1 | SURGERY | USEFUL DIAGNOSTIC MARKER | DIFFERENTIAL-DIAGNOSIS | GLYPICAN-3 | HEP PAR-1 ANTIBODY | PATHOLOGY | METASTATIC ADENOCARCINOMA | TUMORS | CARCINOMA | EXPRESSION | ANTIGEN | Immunohistochemistry | Predictive Value of Tests | Biomarkers, Tumor - analysis | Tissue Array Analysis | United States | Humans | Hepatocytes - pathology | Carcinoma, Hepatocellular - enzymology | Arginase - analysis | Sensitivity and Specificity | Carcinoma, Hepatocellular - pathology | Brazil | Liver Neoplasms - pathology | Cell Differentiation | Liver Neoplasms - enzymology | Hepatocytes - enzymology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
by Saha, Supriya K and Saha, Supriya K and Parachoniak, Christine A and Parachoniak, Christine A and Ghanta, Krishna S and Ghanta, Krishna S and Fitamant, Julien and Fitamant, Julien and Ross, Kenneth N and Ross, Kenneth N and Najem, Mortada S and Najem, Mortada S and Gurumurthy, Sushma and Gurumurthy, Sushma and Akbay, Esra A and Akbay, Esra A and Sia, Daniela and Sia, Daniela and Cornella, Helena and Cornella, Helena and Miltiadous, Oriana and Miltiadous, Oriana and Walesky, Chad and Walesky, Chad and Deshpande, Vikram and Deshpande, Vikram and Zhu, Andrew X and Zhu, Andrew X and Hezel, Aram F and Heze, Aram F and Yen, Katharine E and Yen, Katharine E and Straley, Kimberly S and Straley, Kimberly S and Travins, Jeremy and Travins, Jeremy and Popovici-Muller, Janeta and Popovici-Muller, Janeta and Gliser, Camelia and Gliser, Camelia and Ferrone, Cristina R and Ferrone, Cristina R and Apte, Udayan and Apte, Udayan and Llovet, Josep M and Llovet, Josep M and Wong, Kwok-Kin and Wong, Kwok-Kin and Ramaswamy, Sridhar and Ramaswamy, Sridhar and Bardeesy, Nabeel and Bardeesy, Nabeel
Nature, ISSN 0028-0836, 2014, Volume 513, Issue 7516, pp. 110 - 114
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver... 
PROGENITORS | INTRAHEPATIC CHOLANGIOCARCINOMA | HOMEOSTASIS | LIVER-REGENERATION | MULTIDISCIPLINARY SCIENCES | MUTATION | GROWTH | MICE | PROLIFERATION | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Hepatocyte Nuclear Factor 4 - antagonists & inhibitors | Humans | ras Proteins - metabolism | Hepatocytes - pathology | Male | Hepatocytes - metabolism | Bile Duct Neoplasms - enzymology | Cell Differentiation - genetics | Neoplasm Metastasis | Hepatocyte Nuclear Factor 4 - biosynthesis | Female | Bile Duct Neoplasms - genetics | Cell Lineage - genetics | Cholangiocarcinoma - enzymology | Disease Models, Animal | Cell Division - genetics | Proto-Oncogene Proteins - metabolism | Hepatocyte Nuclear Factor 4 - metabolism | Bile Ducts, Intrahepatic - pathology | Mutant Proteins - genetics | Isocitrate Dehydrogenase - genetics | Mice, Transgenic | Mutant Proteins - metabolism | Proto-Oncogene Proteins - genetics | Hepatocyte Nuclear Factor 4 - genetics | Mutation - genetics | Bile Ducts, Intrahepatic - enzymology | Cholangiocarcinoma - pathology | Animals | Cholangiocarcinoma - genetics | Stem Cells - pathology | Isocitrate Dehydrogenase - metabolism | Glutarates - metabolism | Mice | Bile Duct Neoplasms - pathology | Hepatocytes - enzymology | Index Medicus | Càncer | Diferenciació cel·lular | Gallbladder diseases | Metabolisme | Cell diferentiation | Metabolism | Malalties de la vesícula biliar | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport
by Nagarajan, Arvindhan and Dogra, Shaillay Kumar and Sun, Lisha and Gandotra, Neeru and Ho, Thuy and Cai, Guoping and Cline, Gary and Kumar, Priti and Cowles, Robert A and Wajapeyee, Narendra
Molecular Cell, ISSN 1097-2765, 08/2017, Volume 67, Issue 4, pp. 685 - 701.e6
Metabolic deregulation is a hallmark of human cancers, and the glycolytic and glutamine metabolism pathways were shown to be deregulated in pancreatic ductal... 
GLUT1 | anoikis | glucose | pancreatic cancer | metabolism | PON2 | PATHWAYS | CELLS | ACTIVATED PROTEIN-KINASE | GENE | ONCOGENIC KRAS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SENSITIVITY | ENERGY SENSOR | EXPRESSION | PROGRESSION | P53 | CELL BIOLOGY | Proto-Oncogene Proteins p21(ras) - genetics | Humans | AMP-Activated Protein Kinases - analysis | Glucose Transporter Type 1 - metabolism | Male | Carcinoma, Pancreatic Ductal - genetics | RNA Interference | Time Factors | Transcription, Genetic | Liver Neoplasms - enzymology | Liver Neoplasms - secondary | Lung Neoplasms - enzymology | Liver Neoplasms - genetics | Signal Transduction | Pancreatic Neoplasms - pathology | Tumor Burden | Aryldialkylphosphatase - genetics | Aryldialkylphosphatase - metabolism | Forkhead Box Protein O3 - metabolism | Apoptosis Regulatory Proteins - metabolism | Cell Movement - drug effects | Lung Neoplasms - prevention & control | Mice, Nude | Cell Line, Tumor | Glucose - metabolism | Mutation | AMP-Activated Protein Kinases - genetics | Energy Metabolism - drug effects | AMP-Activated Protein Kinases - metabolism | Gene Expression Regulation, Neoplastic | Tumor Suppressor Protein p53 - genetics | Forkhead Box Protein O3 - genetics | Pancreatic Neoplasms - drug therapy | Transfection | Lung Neoplasms - secondary | Apoptosis Regulatory Proteins - genetics | Female | Antineoplastic Agents - pharmacology | Liver Neoplasms - prevention & control | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Pancreatic Neoplasms - enzymology | Tumor Suppressor Protein p53 - metabolism | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - enzymology | Xenograft Model Antitumor Assays | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Glucose Transporter Type 1 - genetics | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Deregulation | Growth | Pancreatic cancer | Physiological aspects | Genetic transcription | Metastasis | Glucose | Tumor proteins | Dextrose | Glutamine | Glucose metabolism | Medical colleges | Protein kinases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
by Schirripa, M and Bergamo, F and Cremolini, C and Casagrande, M and Lonardi, S and Aprile, G and Yang, Dongyun and Marmorino, F and Pasquini, G and Sensi, E and Lupi, C and De Maglio, G and Borrelli, N and Pizzolitto, S and Fasola, G and Bertorelle, R and Rugge, M and Fontanini, G and Zagonel, V and Loupakis, F and Falcone, A
British Journal of Cancer, ISSN 0007-0920, 06/2015, Volume 112, Issue 12, pp. 1921 - 1928
Background: Despite major advances in the management of metastatic colorectal cancer (mCRC) with liver-only involvement, relapse rates are high and reliable... 
prognostic | metastatic colorectal cancer | BRAF | liver | RAS | SURVIVAL | SURGERY | HEPATECTOMY | MICROSATELLITE INSTABILITY | KRAS STATUS | PATTERNS | HEPATIC RESECTION | PANITUMUMAB | CETUXIMAB | ONCOLOGY | RECURRENCE | ras Proteins - genetics | Colorectal Neoplasms - enzymology | Prognosis | Liver Neoplasms - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Liver Neoplasms - surgery | Male | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Female | Aged | Biomarkers, Tumor - genetics | Mutation | Colorectal Neoplasms - pathology | Genes, ras | Liver Neoplasms - enzymology | Liver Neoplasms - secondary | Index Medicus | Molecular Diagnostics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Activating Mutations in PTPN3 Promote Cholangiocarcinoma Cell Proliferation and Migration and Are Associated With Tumor Recurrence in Patients
by Gao, Qiang and Zhao, Ying–Jun and Wang, Xiao–Ying and Guo, Wei–Jie and Gao, Song and Wei, Lin and Shi, Jie–Yi and Shi, Guo–Ming and Wang, Zhi–Chao and Zhang, Yuan–Nv and Shi, Ying–Hong and Ding, Jie and Ding, Zhen–Bin and Ke, Ai–Wu and Dai, Zhi and Wu, Fei–Zhen and Wang, Hui and Qiu, Zhao–Ping and Chen, Zhi–Ao and Zhang, Zhen–Feng and Qiu, Shuang–Jian and Zhou, Jian and He, Xiang–Huo and Fan, Jia
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 5, pp. 1397 - 1407
Background & Aims The pathogenesis of intrahepatic cholangiocarcinoma (ICC), the second most common hepatic cancer, is poorly understood, and the incidence of... 
Gastroenterology and Hepatology | Phosphorylation | Liver Cancer | Signal Transduction | Carcinogenesis | Keywords | ONCOGENESIS | CANCER | SOMATIC MUTATIONS | PATHOGENESIS | HEPATOCELLULAR-CARCINOMA | DEPHOSPHORYLATES | TYROSINE PHOSPHATOME | GENES | PTPH1 | GASTROENTEROLOGY & HEPATOLOGY | REVEALS | Cell Proliferation | Humans | Gene Expression Regulation, Neoplastic | Bile Duct Neoplasms - enzymology | Exosomes | Transfection | RNA Interference | Time Factors | DNA Mutational Analysis | Liver Neoplasms - pathology | Bile Duct Neoplasms - genetics | Liver Neoplasms - enzymology | Cholangiocarcinoma - enzymology | Bile Ducts, Intrahepatic - pathology | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Neoplasm Invasiveness | Gene Frequency | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Bile Ducts, Intrahepatic - enzymology | Gene Expression Regulation, Enzymologic | Protein Tyrosine Phosphatase, Non-Receptor Type 3 - metabolism | Cholangiocarcinoma - pathology | Phenotype | Cell Line, Tumor | Cholangiocarcinoma - genetics | Bile Duct Neoplasms - pathology | Enzyme Activation | Mutation | Protein Tyrosine Phosphatase, Non-Receptor Type 3 - genetics | Cell Movement | Liver cancer | Relapse | Genetic aspects | Tumors | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text CD95 promotes tumour growth
by Peter, Marcus E and Tumanov, Alexei V and Chen, Lina and Park, Sun-Mi and Sawada, Kenjiro